Jiangsu Aoyang Health Industry Co.ltd. (SHE:002172)
China · Delayed Price · Currency is CNY 4.370
0.00 (0.00%)
Feb 13, 2026, 3:04 PM CST
SHE:002172 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,858 | 1,999 | 2,165 | 2,008 | 1,429 | 1,885 |
Other Revenue | 10.29 | 10.29 | 8.48 | 13.77 | - | - |
| 1,869 | 2,010 | 2,174 | 2,021 | 1,429 | 1,885 | |
Revenue Growth (YoY) | -8.90% | -7.54% | 7.54% | 41.41% | -24.18% | -36.79% |
Cost of Revenue | 1,616 | 1,745 | 1,885 | 1,741 | 989.31 | 1,453 |
Gross Profit | 252.85 | 264.64 | 289.06 | 280.15 | 440.06 | 431.78 |
Selling, General & Admin | 138.63 | 162.56 | 189.61 | 198.57 | 370.95 | 295.23 |
Research & Development | - | - | - | - | - | 1.27 |
Other Operating Expenses | 10.56 | 11.07 | 11.01 | 11.52 | 30.59 | 17.09 |
Operating Expenses | 160.57 | 177.14 | 203.48 | 164.97 | 453.88 | 398.93 |
Operating Income | 92.28 | 87.49 | 85.58 | 115.17 | -13.82 | 32.85 |
Interest Expense | -29.9 | -39.38 | -43.19 | -62.56 | -137.76 | -152.16 |
Interest & Investment Income | 4.63 | 22.5 | 45.19 | 19.04 | 15.85 | 34.72 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.02 | 0.07 | -0.03 | 0.01 |
Other Non Operating Income (Expenses) | -14.93 | -13.82 | -10.74 | -54.46 | -16.64 | -35.99 |
EBT Excluding Unusual Items | 52.1 | 56.81 | 76.87 | 17.26 | -152.4 | -120.57 |
Gain (Loss) on Sale of Investments | -0.85 | -1.31 | - | -15.89 | -3.98 | 23.84 |
Gain (Loss) on Sale of Assets | -0.05 | -0.06 | 0.03 | -0.01 | 8.8 | 111.92 |
Asset Writedown | -0.14 | -0.14 | -1 | -0.05 | -745.14 | -50.88 |
Legal Settlements | - | - | -17.46 | -20 | - | -8.85 |
Other Unusual Items | 9.88 | 9.88 | 11.51 | 17.72 | 53.24 | 29.78 |
Pretax Income | 60.93 | 65.18 | 69.94 | -0.96 | -839.48 | -14.76 |
Income Tax Expense | 18.6 | 23.94 | 19.68 | 14.76 | -11.43 | 32.94 |
Earnings From Continuing Operations | 42.33 | 41.24 | 50.26 | -15.72 | -828.05 | -47.7 |
Earnings From Discontinued Operations | - | - | - | - | -239.15 | -423.53 |
Net Income to Company | 42.33 | 41.24 | 50.26 | -15.72 | -1,067 | -471.22 |
Minority Interest in Earnings | -0.34 | -0.68 | -0.58 | 0.36 | 28.28 | 12.23 |
Net Income | 42 | 40.56 | 49.68 | -15.37 | -1,039 | -458.99 |
Net Income to Common | 42 | 40.56 | 49.68 | -15.37 | -1,039 | -458.99 |
Net Income Growth | -13.82% | -18.36% | - | - | - | - |
Shares Outstanding (Basic) | 811 | 811 | 828 | 768 | 775 | 778 |
Shares Outstanding (Diluted) | 811 | 811 | 828 | 768 | 775 | 778 |
Shares Change (YoY) | -2.01% | -2.03% | 7.78% | -0.91% | -0.34% | 0.64% |
EPS (Basic) | 0.05 | 0.05 | 0.06 | -0.02 | -1.34 | -0.59 |
EPS (Diluted) | 0.05 | 0.05 | 0.06 | -0.02 | -1.34 | -0.59 |
EPS Growth | -12.05% | -16.67% | - | - | - | - |
Free Cash Flow | 209.4 | -28.2 | -9.29 | -226.97 | -254.58 | -51.9 |
Free Cash Flow Per Share | 0.26 | -0.04 | -0.01 | -0.29 | -0.33 | -0.07 |
Gross Margin | 13.53% | 13.17% | 13.30% | 13.86% | 30.79% | 22.91% |
Operating Margin | 4.94% | 4.35% | 3.94% | 5.70% | -0.97% | 1.74% |
Profit Margin | 2.25% | 2.02% | 2.29% | -0.76% | -72.68% | -24.35% |
Free Cash Flow Margin | 11.21% | -1.40% | -0.43% | -11.23% | -17.81% | -2.75% |
EBITDA | 138.22 | 141.28 | 149.83 | 183.18 | 199.8 | 338.71 |
EBITDA Margin | 7.40% | 7.03% | 6.89% | 9.06% | 13.98% | 17.97% |
D&A For EBITDA | 45.95 | 53.79 | 64.25 | 68.01 | 213.63 | 305.87 |
EBIT | 92.28 | 87.49 | 85.58 | 115.17 | -13.82 | 32.85 |
EBIT Margin | 4.94% | 4.35% | 3.94% | 5.70% | -0.97% | 1.74% |
Effective Tax Rate | 30.52% | 36.72% | 28.14% | - | - | - |
Revenue as Reported | 1,869 | 2,010 | 2,174 | 2,021 | 3,029 | 3,083 |
Advertising Expenses | - | 2.46 | 1.91 | 2 | 3.27 | 3.72 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.